Consumers should beware of false, misleading claims, says agency, which has issued warnings to makers.
By HealthDay News
Companies that make false or misleading claims that their products and therapies can treat or even cure autism face possible legal action if they continue, the U.S. Food and Drug Administration has warned them. As part of National Autism Awareness Month in April, the FDA wanted to inform consumers about bogus autism therapies.
MAY